Immune checkpoint inhibitors for advanced oesophageal cancer treated with surgery, radiotherapy or chemotherapy
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors (ICIs) for people with advanced, unresectable or metastatic oesophageal cancer.
Authors
- Yajing Sun (ORCID: https://orcid.org/0000-0003-4286-7422)
- Huan Song (ORCID: https://orcid.org/0000-0003-3845-8079)
- Xingdong Chen (ORCID: https://orcid.org/0000-0003-3763-160X)
- Chen Suo (ORCID: https://orcid.org/0000-0002-5274-4584)
- Yi Fung Chau
- Yurou Xu (ORCID: https://orcid.org/0009-0008-0201-1850)
- Ning Cai (ORCID: https://orcid.org/0000-0002-2331-9773)
- Hao Dong (ORCID: https://orcid.org/0000-0001-9541-1598)
Institutions
- University of Iceland (IS)
- Fudan University (CN)
- West China Medical Center of Sichuan University (CN)
- State Key Laboratory of Genetic Engineering
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1002/14651858.cd014621
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00